Literature DB >> 1447259

Lipids and Dupuytren's disease.

P L Sanderson1, M A Morris, J K Stanley, N R Fahmy.   

Abstract

We studied prospectively the relationship between serum lipids and Dupuytren's disease of the hand in 85 patients, 65 men and 20 women. The Dupuytren patients had significantly higher fasting serum cholesterol and triglyceride levels than did the controls (p < 0.001). The raised levels of serum lipids appeared to be associated with the pathogenesis of Dupuytren's disease, and this may help to explain the high incidence of Dupuytren's disease in alcoholic, diabetic and epileptic patients, since these conditions are also associated with raised serum lipid levels.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1447259

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN： 0301-620X


  11 in total

Review 1.  Frozen shoulder: unravelling the enigma.

Authors:  T D Bunker
Journal:  Ann R Coll Surg Engl       Date:  1997-05       Impact factor: 1.891

2.  The Role of Thrombin and Cell Contractility in Regulating Clustering and Collective Migration of Corneal Fibroblasts in Different ECM Environments.

Authors:  Miguel Miron-Mendoza; Eric Graham; Pouriska Kivanany; Jonathan Quiring; W Matthew Petroll
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-03-03       Impact factor: 4.799

3.  EPIDEMIOLOGICAL ASPECTS OF DUPUYTREN'S DISEASE IN BRAZIL.

Authors:  Hugo Alberto Nakamoto; Reinaldo Borges Gonçalves; Lucas Torres Oliveira; Lucas Sousa Macedo; Marina Tommasini Carrara de Sambuy; Mauricio Pinto Rodrigues; Rames Mattar
Journal:  Acta Ortop Bras       Date:  2022-07-06       Impact factor: 0.683

4.  Epidemiological evaluation of Dupuytren's disease incidence and prevalence rates in relation to etiology.

Authors:  Sandip Hindocha; Duncan Angus McGrouther; Ardeshir Bayat
Journal:  Hand (N Y)       Date:  2009-01-15

5.  Metabolic factors and the risk of Dupuytren's disease: data from 30,000 individuals followed for over 20 years.

Authors:  Mattias Rydberg; Malin Zimmerman; Jin Persson Löfgren; Anders Gottsäter; Peter M Nilsson; Olle Melander; Lars B Dahlin
Journal:  Sci Rep       Date:  2021-07-19       Impact factor: 4.379

6.  The emerging role of Clostridium histolyticum collagenase in the treatment of Dupuytren disease.

Authors:  Alexis Thomas; Ardeshir Bayat
Journal:  Ther Clin Risk Manag       Date:  2010-11-04       Impact factor: 2.423

7.  In vitro study of novel collagenase (XIAFLEX®) on Dupuytren's disease fibroblasts displays unique drug related properties.

Authors:  Farhatullah Syed; Alexis N Thomas; Subir Singh; Venkatesh Kolluru; Susan G Emeigh Hart; Ardeshir Bayat
Journal:  PLoS One       Date:  2012-02-24       Impact factor: 3.240

8.  Epidemiological profile of Dupuytren's disease in Taiwan (Ethnic Chinese): a nationwide population-based study.

Authors:  Chin-Choon Yeh; Kuo-Feng Huang; Chung-Han Ho; Kuan-Ting Chen; Cheng Liu; Jhi-Joung Wang; Chin-Chen Chu
Journal:  BMC Musculoskelet Disord       Date:  2015-02-10       Impact factor: 2.362

9.  Integrative analysis of Dupuytren's disease identifies novel risk locus and reveals a shared genetic etiology with BMI.

Authors:  Megan Major; Malika K Freund; Kathryn S Burch; Nicholas Mancuso; Michael Ng; Dominic Furniss; Bogdan Pasaniuc; Roel A Ophoff
Journal:  Genet Epidemiol       Date:  2019-05-13       Impact factor: 2.135

10.  Dupuytren's Disease Predicts Increased All-Cause and Cancer-Specific Mortality: Analysis of a Large Cohort from the U.K. Clinical Practice Research Datalink.

Authors:  Rachel Yi Ling Kuo; Michael Ng; Daniel Prieto-Alhambra; Dominic Furniss
Journal:  Plast Reconstr Surg       Date:  2020-03       Impact factor: 5.169
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.